In message <[log in to unmask]>, Dr Clara Henig
<[log in to unmask]> writes
>Dear all
>
>What do you know about the utilities of sensitive CRP as a CHD marker?
>Does anyone use it routinely? What are your recommendations?
>
>Thanks
>Clara
>
>------ACB discussion List Information--------
>This is an open discussion list for the academic and clinical
>community working in clinical biochemistry.
>Please note, archived messages are public and can be viewed
>via the internet. Views expressed are those of the individual and
>they are responsible for all message content.
>
>ACB Web Site
>http://www.acb.org.uk
>List Archives
>http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
>List Instructions (How to leave etc.)
>http://www.jiscmail.ac.uk/
There have been a number of publications by Paul Ridker
We use it routinely for priomary risk stratification with the cut-off for low
risk <1, inetremediate 1-3 and high risk >3 (mg/L)
--
Paul Collinson
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|